Home > National Drug Code (NDC) > Lisinopril and Hydrochlorothiazide

Lisinopril and Hydrochlorothiazide - 0378-1012-93 - (lisinopril and hydrochlorothiazide)

Alphabetical Index


Drug Information of Lisinopril and Hydrochlorothiazide

Product NDC: 0378-1012
Proprietary Name: Lisinopril and Hydrochlorothiazide
Non Proprietary Name: lisinopril and hydrochlorothiazide
Active Ingredient(s): 12.5; 10    mg/1; mg/1 & nbsp;   lisinopril and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Lisinopril and Hydrochlorothiazide

Product NDC: 0378-1012
Labeler Name: Mylan Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076113
Marketing Category: ANDA
Start Marketing Date: 20130122

Package Information of Lisinopril and Hydrochlorothiazide

Package NDC: 0378-1012-93
Package Description: 30 TABLET in 1 BOTTLE, PLASTIC (0378-1012-93)

NDC Information of Lisinopril and Hydrochlorothiazide

NDC Code 0378-1012-93
Proprietary Name Lisinopril and Hydrochlorothiazide
Package Description 30 TABLET in 1 BOTTLE, PLASTIC (0378-1012-93)
Product NDC 0378-1012
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lisinopril and hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20130122
Marketing Category Name ANDA
Labeler Name Mylan Pharmaceuticals Inc.
Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
Strength Number 12.5; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Lisinopril and Hydrochlorothiazide


General Information